Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am Nat ; 194(1): E1-E12, 2019 07.
Article in English | MEDLINE | ID: mdl-31251646

ABSTRACT

Despite the ubiquity of disease in nature, the role that disease dynamics play in the compensatory growth response to harvesting has been ignored. We use a mathematical approach to show that harvesting can lead to compensatory growth due to a release from disease-induced mortality. Our findings imply that culling in systems that harbor virulent parasites can reduce disease prevalence and increase population density. Our models predict that this compensation occurs for a broad range of infectious disease characteristics unless the disease induces long-lasting immunity in hosts. Our key insight is that a population can be regulated at a similar density by disease or at reduced prevalence by a combination of culling and disease. We illustrate our predictions with a system-specific model representing wild boar tuberculosis infection, parameterized for central Spain, and find significant compensation to culling. Given that few wildlife diseases are likely to induce long-lived immunity, populations with virulent diseases may often be resilient to harvesting.


Subject(s)
Animal Culling , Models, Biological , Sus scrofa , Tuberculosis/veterinary , Animals , Animals, Wild , Tuberculosis/epidemiology
2.
Prev Vet Med ; 155: 11-20, 2018 Jul 01.
Article in English | MEDLINE | ID: mdl-29786520

ABSTRACT

The Eurasian wild boar (Sus scrofa) is the main wild reservoir of the Mycobacterium tuberculosis complex in Mediterranean woodlands and a key risk factor for cattle tuberculosis (TB) breakdowns. Wild boar vaccination therefore has the potential to be a valuable tool for TB control. We tested two orally delivered vaccines, heat-inactivated Mycobacterium bovis (IV) and BCG, in four sites (two per vaccine type: one Managed and one Natural or unmanaged) during four years. TB was also monitored in 15 unvaccinated sites (spatial control), as well as in all sites from one year prior to intervention (temporal control). The rationale is that by vaccinating 2-6 month old wild boar piglets we can reduce disease at the population level during the study period. This is achievable due to the fast turnover of wild boar populations. Vaccine baits were deployed using selective piglet feeders and this method proved highly successful with uptake rates of 50 to 74% in Natural sites and 89 to 92% in Managed sites. This is relevant for the potential delivery of vaccines to control other diseases, too. Local wild boar TB prevalence at the beginning of the study was already high ranging from 50 to 100%. TB prevalence increased in unvaccinated sites (6%), while a significant decline occurred in the Managed IV site (34%). Changes recorded in the remaining sites were not significant. The short-term impact of vaccination observed in the field was complemented by mathematical modelling, representative of the field system, which examined the long-term impact and showed that vaccination of piglets reduced prevalence and increased abundance at the population level. We conclude that IV could become part of integrated TB control schemes, although its application must be tailored for each specific site.


Subject(s)
Mycobacterium bovis/immunology , Sus scrofa , Tuberculosis/veterinary , Vaccination/veterinary , Administration, Oral , Animals , Animals, Newborn , Animals, Wild , Cattle , Swine , Tuberculosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL